HEATHER DELAGRANGE: Open Payments
NPI 1174029342 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,421 in 58 payments from 17 companies in 2025. Trend: 2023 $580 · 2024 $1,067 · 2025 $1,421
Food & beverage: $1,421
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $278 |
| ACCORD HEALTHCARE, INC. | 10 | $246 |
| Merck Sharp & Dohme LLC | 5 | $123 |
| Janssen Biotech, Inc. | 7 | $122 |
| Sumitomo Pharma America, Inc. | 5 | $111 |
| Boston Scientific Corporation | 1 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $68 |
| Dendreon Pharmaceuticals LLC | 2 | $67 |
| ABBVIE INC. | 3 | $60 |
Products named: Nubeqa, Camcevi, LYNPARZA, ERLEADA, AMS 700, PLUVICTO, GEMTESA, PROVENGE.
Industry payments across IN — which companies pay providers there.
